Leslie Cope

Medicine & Life Sciences

1. Neoplasms 100%
2. Genome 72%
3. Genes 52%
4. Mutation 51%
5. Atlases 45%
6. DNA Methylation 45%
7. Breast Neoplasms 44%
8. Methylation 44%
9. Gene Expression 30%
10. Epigenomics 28%
11. Carcinoma 26%
12. Neoplasm Genes 23%
13. Ovarian Neoplasms 22%
14. DNA 21%
15. Adenocarcinoma 17%
16. Datasets 16%
17. Survival 16%
18. Triple Negative Breast Neoplasms 15%
19. Biomarkers 15%
20. Chromatin 15%
21. Estrogen Receptors 14%
22. CpG Islands 13%
23. Carcinogenesis 13%
24. Pancreatic Neoplasms 12%
25. Oncogenes 12%
26. Exome 12%
27. Cell Line 11%
28. Renal Cell Carcinoma 11%
29. Melanoma 11%
30. Therapeutics 10%
31. Stem Cells 10%
32. T-Lymphocytes 10%
33. Genomics 10%
34. Squamous Cell Carcinoma of Head and Neck 9%
35. Circulating Tumor DNA 9%
36. entinostat 9%
37. High Mobility Group Proteins 9%
38. ABT-737 9%
39. Recurrence 9%
40. Epigenome 9%
41. Heterografts 9%
42. Phenotype 8%
43. Gene Regulatory Networks 8%
44. DNA Copy Number Variations 8%
45. Pluripotent Stem Cells 8%
46. Azacitidine 8%
47. Fine Needle Biopsy 8%
48. Long Noncoding RNA 8%
49. Oligonucleotide Array Sequence Analysis 8%
50. Descemet Membrane 8%